Pages that link to "Q39939612"
Jump to navigation
Jump to search
The following pages link to WNT5A expression increases during melanoma progression and correlates with outcome (Q39939612):
Displaying 50 items.
- The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma (Q24648937) (← links)
- Wnt5a Signaling in Cancer (Q26738408) (← links)
- Energy metabolism in neuroblastoma and Wilms tumor (Q26770341) (← links)
- WNT-5A: signaling and functions in health and disease (Q26777942) (← links)
- Therapy for BRAFi-Resistant Melanomas: Is WNT5A the Answer? (Q26782222) (← links)
- Immune evasion pathways and the design of dendritic cell-based cancer vaccines (Q28076556) (← links)
- Wnt Signaling in Cell Motility and Invasion: Drawing Parallels between Development and Cancer (Q28077330) (← links)
- WNT5A encodes two isoforms with distinct functions in cancers (Q28302422) (← links)
- Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model (Q28306770) (← links)
- Elevated level of Wnt5a protein in localized prostate cancer tissue is associated with better outcome (Q28477590) (← links)
- Wnt5a inhibits the proliferation and melanogenesis of melanocytes (Q28590609) (← links)
- Emphasizing the role of Wnt5a protein expression to predict favorable outcome after radical prostatectomy in patients with low-grade prostate cancer (Q28709995) (← links)
- Methylation and loss of Secreted Frizzled-Related Protein 3 enhances melanoma cell migration and invasion (Q28741295) (← links)
- WNT signalling pathways as therapeutic targets in cancer (Q29615666) (← links)
- A common biological mechanism in cancer and Alzheimer's disease? (Q33606991) (← links)
- Genetic variants of the Wnt signaling pathway as predictors of recurrence and survival in early-stage non-small cell lung cancer patients (Q33705233) (← links)
- Challenging role of Wnt5a and its signaling pathway in cancer metastasis (Review). (Q33769672) (← links)
- WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors. (Q33808166) (← links)
- Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progression (Q33965278) (← links)
- Wnt1 is anti-lymphangiogenic in a melanoma mouse model (Q34273801) (← links)
- Dvl2-dependent activation of Daam1 and RhoA regulates Wnt5a-induced breast cancer cell migration (Q34289087) (← links)
- Wnt5A expression is associated with the tumor metastasis and clinical survival in cervical cancer (Q34371581) (← links)
- Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility. (Q34493922) (← links)
- Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanoma (Q35234354) (← links)
- Silencing of Wnt5a during colon cancer metastasis involves histone modifications (Q36100968) (← links)
- WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer (Q36567558) (← links)
- Regulation of lipid synthesis by the RNA helicase Mov10 controls Wnt5a production (Q36579789) (← links)
- Wnt5a and Ror2 expression associate with the disease progress of primary thyroid lymphoma. (Q36922613) (← links)
- A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion (Q37429052) (← links)
- Heparan sulfate proteoglycan modulation of Wnt5A signal transduction in metastatic melanoma cells. (Q37431129) (← links)
- Noncanonical WNT-5A signaling impairs endogenous lung repair in COPD (Q37549718) (← links)
- The opposing roles of Wnt-5a in cancer (Q37551599) (← links)
- Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2. (Q37570262) (← links)
- Interactions between lens epithelial and fiber cells reveal an intrinsic self-assembly mechanism (Q37626125) (← links)
- Molecular markers of tumor progression in melanoma (Q37641784) (← links)
- The small GTPase ARF6 stimulates β-catenin transcriptional activity during WNT5A-mediated melanoma invasion and metastasis (Q37651978) (← links)
- A re-evaluation of the "oncogenic" nature of Wnt/beta-catenin signaling in melanoma and other cancers (Q37770227) (← links)
- Prognostic tissue markers in melanoma. (Q37924320) (← links)
- Developmental pathways activated in melanocytes and melanoma (Q38238576) (← links)
- WNT signaling: an emerging mediator of cancer cell metabolism? (Q38263093) (← links)
- Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4. (Q38437805) (← links)
- The Wnts of change: How Wnts regulate phenotype switching in melanoma (Q38627456) (← links)
- WNT5A-mediated β-catenin-independent signalling is a novel regulator of cancer cell metabolism (Q38628775) (← links)
- Optimization, validation, and identification of two reliable antibodies for immunodetection of WNT5A. (Q38718130) (← links)
- Dual mechanisms of action of the RNA-binding protein human antigen R explains its regulatory effect on melanoma cell migration. (Q38786887) (← links)
- Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy (Q38867762) (← links)
- WNT5A has anti-prostate cancer effects in vitro and reduces tumor growth in the skeleton in vivo (Q38956252) (← links)
- Interleukin-6 drives melanoma cell motility through p38α-MAPK-dependent up-regulation of WNT5A expression (Q38982133) (← links)
- Targeting c-Met in melanoma: mechanism of resistance and efficacy of novel combinatorial inhibitor therapy (Q38986202) (← links)
- WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells (Q39001226) (← links)